Ropes & Gray advises on rare pharmacy investment
A Warburg Pincus-led investor group is set to take a controlling share in the company following the transaction’s close. The post Ropes & Gray advises on rare pharmacy investment appeared first on…
Read the full articleYou might also wanna read
Warburg Pincus nears a more than $7 billion deal for specialty pharmacy PANTHERx Rare
Private equity firm Warburg Pincus is close to acquiring specialty pharmacy company PANTHERx Rare in a transaction valued at more than $7 bi
Cumberland Pharmaceuticals Inc. (CPIX) Stock: Unveils Special Dividend While Advancing Ifetroban Rare Disease Pipeline
TLDR CPIX declares a $1.50 special dividend after completing the Apotex transaction. Cumberland authorizes a $5M share buyback alongside its
Arsenal Capital Partners acquires majority stake in Velcro fastener manufacturer
Arsenal Capital Partners is acquiring a majority stake in Velcro Cos., a global manufacturer whose iconic hook-and-loop fasteners evolved fr
plasticsnews.com·1mo agoOxylabs Reaches $3.6B Valuation With Warburg Pincus Investment
Founded in Lithuania, Oxylabs has grown from a premium proxy provider into a global data infrastructure platform.
Warburg Pincus Targets Pantherx Rare in $7 Billion Acquisition Deal
Related Stocks: SMCI
Chemical and pharma industry watch: AkzoNobel takeover bid, ARPA-H rare disease initiative, and Strait of Hormuz tensions
Here’s what we’re watching in the chemical and pharmaceutical industries this week
cen.acs.org·2d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.